Scientists pinpoint Ebola's weak spots

Scientists have now have a high-resolution view of exactly how the experimental therapy ZMapp targets Ebola virus. The new study is also the first to show how an antibody in the ZMapp 'drug cocktail' targets a second Ebola virus protein, called sGP, whose vulnerable spots had previously been unknown.